IB Acquisition Corp. (IBACR) stock
IBACRNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBAC
$0.10−0.00 (-3.50%)
Close on Oct 30, 2026Market cap $54.39MP/E –Yield –
Earnings
IB Acquisition's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of IB Acquisition's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
IB Acquisition has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When IB Acquisition puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases IB Acquisition filed with the SEC as exhibits to Form 8-K or 6-K